DNA topoisomerase-targeting chemotherapeutics: what’s new? Selma M. CuyaMary-Ann BjornstiRobert C.A.M. van Waardenburg Review Article 20 May 2017 Pages: 1 - 14
Population pharmacokinetic modelling of doxorubicin and doxorubicinol in children with cancer: is there a relationship with cardiac troponin profiles? Kuhan KunarajahStefanie HennigAndrew S. Moore Original Article 25 April 2017 Pages: 15 - 25
Erratum to: Population pharmacokinetic modelling of doxorubicin and doxorubicinol in children with cancer: is there a relationship with cardiac troponin profiles? Kuhan KunarajahStefanie HennigAndrew S. Moore Erratum 08 June 2017 Pages: 27 - 28
Pharmacokinetics and safety of vismodegib in patients with advanced solid malignancies and hepatic impairment Ghassan K. Abou-AlfaLionel D. LewisRichard A. Graham Original Article 18 May 2017 Pages: 29 - 36
The renal safety and efficacy of combined gemcitabine plus cisplatin and gemcitabine plus carboplatin chemotherapy in Chinese patients with a solitary kidney after nephroureterectomy Peng SunCong XueYan-Xia Shi Original Article 22 May 2017 Pages: 37 - 44
Estimation of glomerular filtration rate in cancer patients with abnormal body composition and relation with carboplatin toxicity M. BretagneA. JouinotJ. Alexandre Original Article 15 May 2017 Pages: 45 - 53
Possible involvement of the lipoxygenase and leukotriene signaling pathways in cisplatin-mediated renal toxicity Osama A. AlkhameesAbdulaziz S. AlroujayeeMohammed M. Ahmed Original Article 13 May 2017 Pages: 55 - 64
Is there any predictor for hypersensitivity reactions in gynecologic cancer patients treated with paclitaxel-based therapy? Tadashi AoyamaMasashi TakanoKenichi Furuya Original Article 10 May 2017 Pages: 65 - 69
Cellular effect and efficacy of carfilzomib depends on cellular net concentration gradient Julia SchäferLukas WeltiJohanna Weiss Original Article 12 May 2017 Pages: 71 - 79
Phase I/II study of bi-weekly XELIRI plus bevacizumab treatment in patients with metastatic colorectal cancer resistant to oxaliplatin-based first-line chemotherapy Tsunekazu MizushimaMutsumi FukunagaMasaki Mori Original Article 16 May 2017 Pages: 81 - 90
The cardiac glycoside oleandrin induces apoptosis in human colon cancer cells via the mitochondrial pathway Li PanYuming ZhangFan Deng Original Article 08 June 2017 Pages: 91 - 100
Prognostic value of chemotherapy-resistant CK19mRNA-positive circulating tumor cells in patients with advanced/metastatic non-small cell lung cancer G. MilakiI. MessaritakisV. Georgoulias Original Article 18 May 2017 Pages: 101 - 108
ABCC4 functional SNP in the 3′ splice acceptor site of exon 8 (G912T) is associated with unfavorable clinical outcome in children with acute lymphoblastic leukemia Hamzeh Mesrian TanhaSoheila RahgozarMarjan Mojtabavi Naeini Original Article 26 May 2017 Pages: 109 - 117
Prospective multicenter phase II study of gemcitabine plus cisplatin in patients with unresectable gallbladder cancer Yoshiki HirookaTakuya IshikawaHidemi Goto Original Article 23 May 2017 Pages: 119 - 125
Allred score is a promising predictor of prognosis and medroxyprogesterone acetate efficacy in patients with endometrial cancer Mayu YunokawaHiroshi YoshidaKenji Tamura Original Article 24 May 2017 Pages: 127 - 134
UGT1A1*6 polymorphisms are correlated with irinotecan-induced neutropenia: a systematic review and meta-analysis Xue ZhangJia-Fu YinXue-Mei Chen Original Article 05 June 2017 Pages: 135 - 149
βIII-tubulin enhances efficacy of cabazitaxel as compared with docetaxel Gregoriy SmiyunOlga AzarenkoMary Ann Jordan Original Article 31 May 2017 Pages: 151 - 164
Population pharmacokinetic analyses of the effect of carboplatin pretreatment on olaparib in recurrent or refractory women’s cancers Cody J. PeerJung-Min LeeWilliam D. Figg Original Article 02 June 2017 Pages: 165 - 175
Differential expression pattern of protein markers for predicting chemosensitivity of dexamethasone-based chemotherapy of B cell acute lymphoblastic leukemia Nasrin Dehghan-NayeriPeyman EshghiAhmad Gharehbaghian Original Article 05 June 2017 Pages: 177 - 185
Clinical significance of systemic chemotherapy after curative resection of metachronous pulmonary metastases from colorectal cancer Sungwoo ParkByung Woog KangSun Ah Lee Original Article 08 June 2017 Pages: 187 - 193
Phase II study of induction gemcitabine and S-1 followed by chemoradiotherapy and systemic chemotherapy using S-1 for locally advanced pancreatic cancer Kentaro SudoRyusuke HaraTaketo Yamaguchi Original Article 08 June 2017 Pages: 195 - 202
Efficacy and safety of postoperative bio-chemoradiotherapy using cetuximab and docetaxel for high-risk head and neck cancer patients in Japan Goshi NishimuraOsamu ShionoNobuhiko Oridate Original Article 08 June 2017 Pages: 203 - 207
Prognostic factors in patients with advanced biliary tract cancer treated with first-line gemcitabine plus cisplatin: retrospective analysis of 740 patients Bum Jun KimJaewon HyungHeung-Moon Chang Original Article 08 June 2017 Pages: 209 - 215
Carfilzomib and lenalidomide response related to VEGF and VEGFR2 germline polymorphisms Tristan M. SissungCody J. PeerWilliam D. Figg Short Communication 09 May 2017 Pages: 217 - 221